3M India (523395) Q4 25/26 earnings summary

Executive summary

• Achieved 16.8% sales growth in Q4 and 14.5% for the full year compared to prior periods.

• All business segments posted double-digit growth for the year, led by Health Care.

• EBITDA, PBT, and PAT grew strongly both sequentially and year-over-year.

• Board recommended a total dividend of Rs. 506 per share, including a special dividend.

Financial highlights

• Q4 FY26 revenue: Rs. 1,399 crore, up 16.8% YoY; full year: Rs. 5,090 crore, up 14.5% YoY.

• Q4 EBITDA: Rs. 269 crore (+12.2% YoY); full year EBITDA: Rs. 1,035 crore (+23.2% YoY).

• Q4 PAT: Rs. 215 crore (+201.7% YoY); full year PAT: Rs. 522 crore (+9.7% YoY).

• EPS for FY26: Rs. 463.66 (basic and diluted).

Outlook and guidance

• Management expects continued growth across all business segments, with Health Care leading.

• Focus remains on customer engagement and supply chain execution.